Case-based considerations in the treatment of actinic keratoses: Utilizing combination or sequential therapy with 5-fluorouracil cream and destructive treatments

Journal of Drugs in Dermatology

Volumn 9, Issue 7, 2010, Pages 864-869

  Han, Anne ^a   Penrose, Carolin ^b   Goldsmith, Arathi ^c   Marmur, Ellen S ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c NEW YORK INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; FLUOROURACIL; TRICHLOROACETIC ACID; ANTINEOPLASTIC ANTIMETABOLITE;

ABSENCE OF SIDE EFFECTS; ACTINIC KERATOSIS; ADULT; AGED; APPLICATION SITE ERYTHEMA; APPLICATION SITE IRRITATION; ARM; ARTICLE; BASAL CELL CARCINOMA; CASE REPORT; CHEEK; CHEMOSURGERY; CREAM; CRYOTHERAPY; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ERYTHEMA; FACE; FEMALE; FOLLOW UP; HAND; HUMAN; HYPERPIGMENTATION; MALE; MALIGNANT LENTIGO; MICRODERMABRASION; MICROSURGERY; NECK; NOSE; PHOTODYNAMIC THERAPY; SHOULDER; SKIN BIOPSY; SKIN DEFECT; SKIN DISCOMFORT; SKIN INFLAMMATION; SKIN MANIFESTATION; SQUAMOUS CELL CARCINOMA; TREATMENT DURATION; TREATMENT RESPONSE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PHOTOCHEMOTHERAPY; SKIN TUMOR;

AGED; AGED, 80 AND OVER; ANTIMETABOLITES, ANTINEOPLASTIC; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; CRYOTHERAPY; FEMALE; FLUOROURACIL; HUMANS; KERATOSIS, ACTINIC; MALE; MIDDLE AGED; PHOTOCHEMOTHERAPY; SKIN NEOPLASMS;

EID: 77955907903     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Clark E, Scerri L. Superficial and medium-depth chemical peels. Clin Dermatol. 2008;26:209-218. (Pubitemid 351620990)
2. Cockerell CJ, Wharton JR. New histopathological classification of actinic keratosis (incipient intraepidermal squamous cell carcinoma). J Drugs Dermatol. 2005;4:462-467.
3. Cooper KD, Fox P, Neises G, Katz SI. Effects of ultraviolet radiation on human epidermal cell alloantigen presentation: Initial depression of Langerhans cell-dependent function is followed by the appearance of T6- Dr+ cells that enhance epidermal alloantigen presentation. J Immunol. 1985;134:129-137. (Pubitemid 15191487)
4. Salasche SJ. Epidemiology of actinic keratoses and squamous cell carcinoma. J Am Acad Dermatol. 2000;42(1 Pt 2):S4-S7. (Pubitemid 30481723)
5. Marks R, Rennie G, Selwood TS. Malignant transformation of solar keratoses to squamous cell carcinoma. Lancet. 1988;1:795-797. (Pubitemid 18094914)
6. Glogau RG. The risk of progression to invasive disease. J Am Acad Dermatol. 2000;42(1 Pt 2):S23-S24. (Pubitemid 30481727)
7. Criscione VD, Weinstock MA, Naylor MF, et al. Natural history and malignant progression of actinic keratoses: The VATTC trial [abstract]. J Invest Dermatol. 2008;128(Suppl 1):S85.
8. Fuchs A, Marmur E. The kinetics of skin cancer: Progression of actinic keratosis to squamous cell carcinoma. Dermatol Surg. 2007;33:1099-1101. (Pubitemid 47339694)
9. Berman B, Bienstock L, Kuritzky L, et al. Actinic keratoses: Sequelae and treatments. Recommendations from a consensus panel. J Fam Pract. 2006;55(Suppl):1-8.
10. Gold MH, Nestor MS. Current treatments of actinic keratosis. J Drugs Dermatol. 2006;5(2 Suppl):17-25.
11. Gilbert DJ. Treatment of actinic keratoses with sequential combination of 5-fluorouracil and photodynamic therapy. J Drugs Dermatol. 2005;4:161-163.
12. Piacquadio DJ, Chen DM, Farber HF, et al. Photodynamic therapy with aminolevulinic acid topical solution and visible blue light in the treatment of multiple actinic keratoses of the face and scalp: Investigator-blinded, phase 3, multicenter trials. Arch Dermatol. 2004;140:41-46. (Pubitemid 38090269)
13. Freeman M, Vinciullo C, Francis D, et al. A comparison of photodynamic therapy using topical methyl aminolevulinate (Metvix) with single cycle cryotherapy in patients with actinic keratosis: a prospective, randomized study. J Dermatolog Treat. 2003;14:99-106. (Pubitemid 36648700)
14. Mastrolonardo M. Topical diclofenac 3% gel plus cryotherapy for treatment of multiple and recurrent actinic keratoses. Clin Exp Dermatol. 2009;34:33-35.
15. Tan JK, Thomas DR, Poulin Y, et al. Efficacy of imiquimod as an adjunct to cryotherapy for actinic keratoses. J Cutan Med Surg. 2007;11:195-201.
16. Jorizzo J, Weiss J, Vamvakias G. One-week treatment with 0.5% fluorouracil cream prior to cryosurgery in patients with actinic keratoses: a double-blind, vehicle-controlled, long-term study. J Drugs Dermatol. 2006;5:133-139.
17. Jorizzo J, Weiss J, Furst K, VandePol C. One-week treatment with topical 0.5% fluorouracil followed by adjunctive cryosurgery in treatment of actinic keratoses: Six-month follow up [abstract]. J Am Acad Dermatol. 2004;50(Suppl):P128.
18. Lubritz RR, Smolewski SA. Cryosurgery cure rate of actinic keratoses. J Am Acad Dermatol. 1982;7:631-632. (Pubitemid 12000529)
19. Thai K-E, Fergin P, Freeman M, et al. A prospective study of the use of cryosurgery for the treatment of actinic keratoses. Int J Dermatol. 2004;43:687-692. (Pubitemid 39276301)
20. Hantash BM, Stewart DB, Cooper ZA, et al. Facial resurfacing for nonmelanoma skin cancer prophylaxis. Arch Dermatol. 2006;142:976-982. (Pubitemid 44268473)
21. Janmeja M, Licata A. Patient survey of trichloroacetic acid treatment of facial actinic keratoses. Arch Dermatol. 1999;135:352. (Pubitemid 29159227)
22. Katz BE. The fluor-hydroxy pulse peel: A pilot evaluation of a new superficial chemical peel. Cosmet Dermatol. 1995;8:24-30.
23. Newman N, Newman A, Moy LS, et al. Clinical improvement of photoaged skin with 50% glycolic acid. A double-blind vehicle-controlled study. Dermatol Surg. 1996;22:455-460.
24. Marrero GM, Katz BE. The new fluor-hydroxy pulse peel. A combination of 5-fluorouracil and glycolic acid. Dermatol Surg. 1998;24:973-978. (Pubitemid 28453045)
25. Kormeili T, Yamauchi PS, Lowe NJ. Topical photodynamic therapy in clinical dermatology. Br J Dermatol. 2004;150:1061-1069. (Pubitemid 38932274)
26. Jeffes EW, McCullough JL, Weinstein GD, et al. Photodynamic therapy of actinic keratoses with topical aminolevulinic acid hydrochloride and fluorescent blue light. J Am Acad Dermatol. 2001;45:96-104. (Pubitemid 32655701)
27. Kurwa HA, Yong-Gee SA, Seed PT, et al. A randomized paired comparison of photodynamic therapy and topical 5-fluorouracil in the treatment of actinic keratoses. J Am Acad Dermatol. 1999;41(3 Pt 1):414-418. (Pubitemid 29418508)
28. Loven K, Stein L, Furst K, Levy S. Evaluation of the efficacy and tolerability of 0.5% fluorouracil cream and 5% fluorouracil cream applied to each side of the face in patients with actinic keratosis. Clin Ther. 2002;24:990-1000. (Pubitemid 34734743)
29. Alomar A, Bichel J, McRae S. Vehicle-controlled, randomized, double-blind study to assess safety and efficacy of imiquimod 5% cream applied once daily 3 days per week in one or two courses of treatment of actinic keratoses on the head. Br J Dermatol. 2007;157:133-141. (Pubitemid 46934262)
30. Korman N, Moy R, Ling M, et al. Dosing with 5% imiquimod cream 3 times per week for the treatment of actinic keratosis: Results of two phase 3, randomized, double-blind, parallel-group, vehicle-controlled trials. Arch Dermatol. 2005;141:467-473. (Pubitemid 40547405)
31. Jorizzo J, Dinehart S, Matheson R, et al. Vehicle-controlled, double-blind, randomized study of imiquimod 5% cream applied 3 days per week in one or two courses of treatment for actinic keratoses on the head. J Am Acad Dermatol. 2007;57:265-268. (Pubitemid 47048863)
32. Gebauer K, Brown P, Varigos G. Topical diclofenac in hyaluronan gel for the treatment of solar keratoses. Australas J Dermatol. 2003;44:40-43. (Pubitemid 36246421)
33. Rivers JK, Arlette J, Shear N, et al. Topical treatment of actinic keratoses with 3.0% diclofenac in 2.5% hyaluronan gel. Br J Dermatol. 2002;146:94-100. (Pubitemid 34158414)
34. Rivers JK, McLean DI. An open study to assess the efficacy and safety of topical 3% diclofenac in a 2.5% hyaluronic acid gel for the treatment of actinic keratoses. Arch Dermatol. 1997;133:1239-1242. (Pubitemid 27443816)
35. Jorizzo J, Weiss J, Furst K, et al. Effect of a 1-week treatment with 0.5% topical fluorouracil on occurrence of actinic keratosis after cryosurgery: A randomized, vehicle-controlled clinical trial. Arch Dermatol. 2004;140:813-816. (Pubitemid 38917849)
36. Berlin JM, Rigel DS. Diclofenac sodium 3% gel in the treatment of actinic keratoses postcryosurgery. J Drugs Dermatol. 2008;7:669-673.
37. Hodges A, Smoller BR. Immunohistochemical comparison of p16 expression in actinic keratoses and squamous cell carcinomas of the skin. Mod Pathol. 2002;15:1121-1125. (Pubitemid 35435128)